Yousif Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$728K Buy
15,656
+104
+0.7% +$5K 0.01% 1212
2026
Q1
$804K Sell
15,552
-198
-1% -$10.1K 0.01% 1166
2025
Q4
$785K Sell
15,750
-1,821
-10% -$88.5K 0.01% 1207
2025
Q3
$840K Sell
17,571
-3,461
-16% -$139K 0.01% 1192
2025
Q2
$663K Buy
21,032
+305
+1% +$9.78K 0.01% 1341
2025
Q1
$679K Sell
20,727
-504
-2% -$17.9K 0.01% 1303
2024
Q4
$768K Sell
21,231
-425
-2% -$15K 0.01% 1292
2024
Q3
$675K Sell
21,656
-595
-3% -$18.6K 0.01% 1361
2024
Q2
$595K Sell
22,251
-2,466
-10% -$71.5K 0.01% 1388
2024
Q1
$843K Sell
24,717
-2,525
-9% -$75.2K 0.01% 1288
2023
Q4
$788K Sell
27,242
-1,418
-5% -$37.6K 0.01% 1339
2023
Q3
$790K Sell
28,660
-1,913
-6% -$58.2K 0.01% 1259
2023
Q2
$919K Sell
30,573
-1,579
-5% -$55.3K 0.01% 1204
2023
Q1
$1.16M Sell
32,152
-3,685
-10% -$142K 0.02% 1069
2022
Q4
$1.28M Sell
35,837
-8,975
-20% -$312K 0.02% 1037
2022
Q3
$1.52M Sell
44,812
-648
-1% -$21.1K 0.02% 928
2022
Q2
$1.31M Sell
45,460
-4,620
-9% -$132K 0.02% 1081
2022
Q1
$1.62M Sell
50,080
-155
-0.3% -$4.75K 0.02% 1093
2021
Q4
$1.47M Buy
+50,235
New +$1.52M 0.02% 1185

Other funds holding SUPN

Yousif Capital Management's SUPN Position: Q2 2026 in Review

Yousif Capital Management increased its Supernus Pharmaceuticals (SUPN) stake by 0.67% in Q2 2026, buying an estimated $5K and bringing the position to 15,656 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1212.

Yousif Capital Management first reported a position in SUPN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.62M in Q1 2022. 44 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Yousif Capital Management held 15,656 shares of Supernus Pharmaceuticals worth $728K as of Q2 2026.
  • Yousif Capital Management bought 104 Supernus Pharmaceuticals shares in Q2 2026, an estimated $5K.
  • Supernus Pharmaceuticals made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1212 holding.
  • Yousif Capital Management first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Supernus Pharmaceuticals position peaked at $1.62M in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.